PRIMECAP Management (Trades, Portfolio) has recently increased its investment in Biogen Inc (NASDAQ:BIIB), a notable move that underscores the firm's confidence in the biotechnology company. The addition has adjusted PRIMECAP Management (Trades, Portfolio)'s position in Biogen Inc to 3.55% of its portfolio, representing an 11.22% stake in the company.
Fortrea Stock: High Risk And Low Upside Potential (NASDAQ:FTRE) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
HQH: Disappointing Track Record (NYSE:HQH) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Baillie Gifford (Trades, Portfolio), a renowned investment management firm, has recently increased its investment in Moderna Inc (NASDAQ:MRNA), a leader in the biotechnology industry. This transaction has brought Baillie Gifford (Trades, Portfolio)'s total share count in Moderna to 45,654,527, representing a significant position size of 3.33% in the firm's portfolio and 11.97% of the firm's holdings in the traded stock.
On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a significant adjustment to its investment portfolio by reducing its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY). The transaction involved the sale of 1,196,042 shares, which resulted in a 14.65% decrease in Baillie Gifford (Trades, Portfolio)'s holdings in the company.